HK1004889A1 - Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases - Google Patents

Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases

Info

Publication number
HK1004889A1
HK1004889A1 HK98104059A HK98104059A HK1004889A1 HK 1004889 A1 HK1004889 A1 HK 1004889A1 HK 98104059 A HK98104059 A HK 98104059A HK 98104059 A HK98104059 A HK 98104059A HK 1004889 A1 HK1004889 A1 HK 1004889A1
Authority
HK
Hong Kong
Prior art keywords
treatment
pharmaceutical formulations
formulations containing
peripheral vascular
vascular diseases
Prior art date
Application number
HK98104059A
Inventor
Roberto Vescovini
Maria Jose Magistretti
Romano Vitali
Original Assignee
Idb Holding Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idb Holding Spa filed Critical Idb Holding Spa
Publication of HK1004889A1 publication Critical patent/HK1004889A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
HK98104059A 1990-05-09 1998-05-12 Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases HK1004889A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909010389A GB9010389D0 (en) 1990-05-09 1990-05-09 Pharmaceutical formulations for the treatment of peripheral vascular diseases

Publications (1)

Publication Number Publication Date
HK1004889A1 true HK1004889A1 (en) 1998-12-11

Family

ID=10675691

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104059A HK1004889A1 (en) 1990-05-09 1998-05-12 Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases

Country Status (5)

Country Link
CH (1) CH682454A5 (en)
FR (1) FR2661831B1 (en)
GB (2) GB9010389D0 (en)
HK (1) HK1004889A1 (en)
IT (1) IT1257884B (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2108993A1 (en) * 1970-10-28 1972-05-26 Forschag Vincamine alkaloid fraction - with sedative and vasoregulating effect
FR2255890B1 (en) * 1973-12-28 1978-01-13 Centre Etd Ind Pharma
FR2255885B1 (en) * 1973-12-28 1977-09-09 Centre Etd Ind Pharma
IL60613A (en) * 1979-08-16 1983-12-30 Richter Gedeon Vegyeszet Dermatological compositions applicable directly to the skin comprising an eburnamenine derivative and process for their preparation
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
DE3586859D1 (en) * 1984-03-07 1993-01-07 Roshdy Ismail AGENTS FOR TREATING AND PROTECTING THE SKIN.
EP0266968A3 (en) * 1986-11-03 1988-08-24 Gérard G. Cohen Gelled ointment of vasodilating agent

Also Published As

Publication number Publication date
FR2661831B1 (en) 1995-04-28
IT1257884B (en) 1996-02-16
CH682454A5 (en) 1993-09-30
GB9010389D0 (en) 1990-06-27
ITMI911206A1 (en) 1992-11-03
GB9109887D0 (en) 1991-07-03
GB2243779A (en) 1991-11-13
GB2243779B (en) 1994-06-15
ITMI911206A0 (en) 1991-05-03
FR2661831A1 (en) 1991-11-15

Similar Documents

Publication Publication Date Title
AP9000206A0 (en) Treatment of conditions & diseases
HUT70034A (en) Process for preparing pharmaceutical compositions containing dipyridamole for the treatment of proliferative diseases
EP0243002A3 (en) Pharmaceutical composition for the treatment of periodontal diseases
EP0799617A3 (en) Therapeutic agent for neurological diseases
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
HU9301252D0 (en) Medical preparative for treatment of prolonged time of coagulation
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
ZA875847B (en) Pharmaceutical compositions for the treatment of occlusive vascular diseases
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
IL86753A0 (en) Pharmaceutical compositions for treatment of lupus
PT84755A (en) Process for the preparation of a pharmaceutical composition for the treatment of skin diseases
HU9204028D0 (en) Medical preparative for treatment of diseases of mamma
AU8516891A (en) Acid treatment for decaffeination of coffee
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
ZA914435B (en) Treatment of disease
GB2243779B (en) Pharmaceutical formulations containing vincamine for treatment of peripheral vascular diseases
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
IL109235A0 (en) Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
GB9216360D0 (en) Treatment of blood
KR0139105B1 (en) Paromomycin or derivatives thereof for parenteral treatment of human parasitic diseases
GB9013878D0 (en) Novel benzothiazepine esters,their preparation and formulations for therapeutic use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)